Sandu Pharmaceuticals Limited (BOM:524703)
India
· Delayed Price · Currency is INR 51.54
-0.88 (-1.68%)
At close: Jun 9, 2025
Sandu Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 6, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Market Capitalization | 503 | 473 | 554 | 593 | 620 | 253 | Upgrade
|
| Market Cap Growth | -14.64% | -14.64% | -6.51% | -4.32% | 144.92% | 204.17% | Upgrade
|
| Enterprise Value | 481 | 445 | 512 | 532 | 582 | 212 | Upgrade
|
| Last Close Price | 52.06 | 48.99 | 56.68 | 51.04 | 68.04 | 30.60 | Upgrade
|
| PE Ratio | 32.54 | 30.50 | 37.94 | 39.01 | 39.00 | 23.17 | Upgrade
|
| PS Ratio | 0.75 | 0.70 | 0.82 | 0.91 | 0.95 | 0.43 | Upgrade
|
| PB Ratio | 1.20 | 1.13 | 1.37 | 1.51 | 1.70 | 0.76 | Upgrade
|
| P/TBV Ratio | 1.20 | 1.13 | 1.37 | 1.51 | 1.70 | 0.76 | Upgrade
|
| P/FCF Ratio | 4836.07 | 4550.88 | - | - | 575.52 | 3.39 | Upgrade
|
| P/OCF Ratio | 53.03 | 49.90 | 72.96 | 268.24 | 65.33 | 3.33 | Upgrade
|
| EV/Sales Ratio | 0.72 | 0.66 | 0.76 | 0.81 | 0.89 | 0.36 | Upgrade
|
| EV/EBITDA Ratio | 17.40 | 16.10 | 24.03 | 22.90 | 21.61 | 10.69 | Upgrade
|
| EV/EBIT Ratio | 22.98 | 21.25 | 29.90 | 27.02 | 24.85 | 13.21 | Upgrade
|
| EV/FCF Ratio | 4626.89 | 4279.97 | - | - | 540.75 | 2.84 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | - | - | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.17 | 0.17 | 0.03 | - | - | 0.01 | Upgrade
|
| Debt / FCF Ratio | 45.91 | 45.91 | - | - | - | 0.00 | Upgrade
|
| Asset Turnover | 1.24 | 1.24 | 1.26 | 1.26 | 1.36 | 1.33 | Upgrade
|
| Inventory Turnover | 2.43 | 2.43 | 2.61 | 2.60 | 3.38 | 2.85 | Upgrade
|
| Quick Ratio | 0.61 | 0.61 | 0.58 | 0.53 | 0.72 | 1.37 | Upgrade
|
| Current Ratio | 2.18 | 2.18 | 2.10 | 1.84 | 1.99 | 2.44 | Upgrade
|
| Return on Equity (ROE) | 3.76% | 3.76% | 3.66% | 4.02% | 4.54% | 3.48% | Upgrade
|
| Return on Assets (ROA) | 2.42% | 2.42% | 2.01% | 2.38% | 3.04% | 2.27% | Upgrade
|
| Return on Capital (ROIC) | 3.15% | 3.15% | 2.68% | 3.25% | 4.19% | 3.13% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.80% | 4.80% | 4.10% | 4.90% | 6.30% | 4.70% | Upgrade
|
| Earnings Yield | 3.09% | 3.28% | 2.63% | 2.56% | 2.56% | 4.32% | Upgrade
|
| FCF Yield | 0.02% | 0.02% | -1.20% | -1.43% | 0.17% | 29.49% | Upgrade
|
| Dividend Yield | 1.54% | 1.63% | 1.41% | 1.47% | 1.10% | 1.63% | Upgrade
|
| Payout Ratio | 49.81% | 49.81% | 49.59% | 43.46% | 19.94% | - | Upgrade
|
| Buyback Yield / Dilution | -0.38% | -0.38% | -2.42% | -10.93% | -20.08% | - | Upgrade
|
| Total Shareholder Return | 1.14% | 1.25% | -1.01% | -9.46% | -18.98% | 1.63% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.